Benzinga | Nov 15, 2021 10:45AM EST

Raymond James Downgrades Catalyst Biosciences to Market Perform

Raymond James analyst Timur Ivannikov downgrades Catalyst Biosciences (NASDAQ:CBIO) from Outperform to Market Perform.